GGrantIndex
← Leaderboards

Roy S Herbst

University Of Texas Md Anderson Can Ctr

$12,300,874
Attributed
$14,332,184
Total exposure
14
Grants
12
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.8M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$39,570,668 · 15

By mechanism

P50$30,236,158 · 9
R01$2,772,785 · 1
T32$2,620,089 · 1
UG1$2,213,006 · 1
U54$1,187,008 · 2
U10$541,622 · 1

Most similar at University Of Texas Md Anderson Can Ctr

Same institution · by research overlap

Others in their field

Top investigators on “Programs

Research focus

ProgramsYale Cancer CenterMalignant Neoplasm Of LungResearch PersonnelPersonalized MedicineMalignant NeoplasmsFundingCancer TherapyBiologyCollaborationsClinical ResearchAnticancer ResearchLeadershipInnovationClinical TrialsEnsureAwardNovel TherapeuticsInstitutionOutreachCancer PatientEpidermal Growth Factor ReceptorFutureGrant

Grant awards (61)

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,341,652
P50 · FY2025 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$510,054
T32 · FY2025 · CA · contact PI
Core A: Administrative Core$222,211
P50 · FY2025 · CA · contact PI
Developmental Research Program$118,407
P50 · FY2025 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,137,785
P50 · FY2024 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$489,880
T32 · FY2024 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$218,588
P50 · FY2024 · CA · contact PI
Core A: Administrative Core$167,278
P50 · FY2024 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$104,728
P50 · FY2024 · CA · contact PI
Yale Cancer Center NCTN LAPS$83,000
UG1 · FY2024 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,069,846
P50 · FY2023 · CA · contact PI
Yale Cancer Center NCTN LAPS$879,128
UG1 · FY2023 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$330,320
T32 · FY2023 · CA · contact PI
Core A: Administrative Core$162,053
P50 · FY2023 · CA · contact PI
Yale Cancer Center NCTN LAPS$120,000
UG1 · FY2023 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$101,452
P50 · FY2023 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,046,999
P50 · FY2022 · CA · contact PI
Yale Cancer Center NCTN LAPS$484,894
UG1 · FY2022 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$306,652
T32 · FY2022 · CA · contact PI
Core A: Administrative Core$164,130
P50 · FY2022 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$104,834
P50 · FY2022 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,003,668
P50 · FY2021 · CA · contact PI
Yale Cancer Center NCTN LAPS$645,984
UG1 · FY2021 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$308,653
T32 · FY2021 · CA · contact PI
Core A: Administrative Core$154,766
P50 · FY2021 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$89,611
P50 · FY2021 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,207,890
P50 · FY2020 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$345,257
T32 · FY2020 · CA · contact PI
Core A: Administrative Core$182,204
P50 · FY2020 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$109,089
P50 · FY2020 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,134,771
P50 · FY2019 · CA · contact PI
Yale Cancer Center Advanced Training Program for Physician-Scientists (YCC-ATPP)$329,273
T32 · FY2019 · CA · contact PI
Administrative Core$141,342
P50 · FY2019 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$125,258
P50 · FY2019 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,507,598
P50 · FY2018 · CA · contact PI
Administrative Core$909,968
P50 · FY2018 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$50,265
P50 · FY2018 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,300,000
P50 · FY2017 · CA · contact PI
MicroRNA-based interventions to prevent progression from lung preneoplasia to adenocarcinoma$207,600
P50 · FY2017 · CA · contact PI
Administrative Core$148,979
P50 · FY2017 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$143,616
P50 · FY2017 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,161,996
P50 · FY2016 · CA · contact PI
Administrative Core$841,293
P50 · FY2016 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$715,091
P50 · FY2016 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$47,249
P50 · FY2016 · CA · contact PI
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer$2,185,000
P50 · FY2015 · CA · contact PI
Administrative Core$860,745
P50 · FY2015 · CA · contact PI
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways$554,459
R01 · FY2015 · CA · contact PI
Yale SPORE in Lung Cancer Developmental Research Program$48,196
P50 · FY2015 · CA · contact PI
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways$541,243
R01 · FY2014 · CA · contact PI
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways$527,883
R01 · FY2013 · CA · contact PI
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways$564,855
R01 · FY2012 · CA · contact PI
Personalizing NSCLC Therapy: Exploiting KRAS activated pathways$584,345
R01 · FY2011 · CA · contact PI
U10 Full Member Application Affiliated with SWOG$325,685
U10 · FY2010 · CA · contact PI
U10 Ful Member Application Affiliated with SWOG$215,937
U10 · FY2009 · CA · contact PI
Core--Clinical trials$296,752
U54 · FY2002 · CA
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors$296,752
U54 · FY2002 · CA
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors$296,752
U54 · FY2001 · CA
Core--Clinical trials$296,752
U54 · FY2001 · CA
Core--Clinical trials$0
U54 · FY2001 · CA
Phase I trial of antiangiogenic agent SU6668 in Pt w solid tumors$0
U54 · FY2001 · CA